Fiche publication
Date publication
mai 2025
Journal
The Cochrane database of systematic reviews
Auteurs
Membres identifiés du Cancéropôle Est :
Pr WESTEEL Virginie
,
Dr EBERST Guillaume
Tous les auteurs :
Marchal C, Eberst G, Calais F, Westeel V, Malouf R
Lien Pubmed
Résumé
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To compare, via a network meta-analysis, the effectiveness and safety of different immunotherapy agents that are administered in a perioperative setting to people with resectable non small-cell lung cancer To perform indirect comparisons in order to generate a clinically meaningful hierarchy of perioperative strategies of immunotherapy administration for overall survival in operable people with resectable non small-cell lung cancer.
Mots clés
Humans, Carcinoma, Non-Small-Cell Lung, mortality, Lung Neoplasms, mortality, Immunotherapy, methods, Randomized Controlled Trials as Topic, Perioperative Care, methods, Network Meta-Analysis as Topic, Immune Checkpoint Inhibitors, therapeutic use, Meta-Analysis as Topic, Nivolumab, therapeutic use, Antineoplastic Agents, Immunological, therapeutic use
Référence
Cochrane Database Syst Rev. 2025 05 19;5(5):CD015819
